Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases [PDF]
Cancer Medicine, 2023 Background Distinguishing between central nervous system lymphoma (CNSL) and CNS infectious and/or demyelinating diseases, although clinically important, is sometimes difficult even using imaging strategies and conventional cerebrospinal fluid (CSF ...
Chisako Iriyama +18 more
doaj +2 more sources
Macrophages and Autoantibodies in Demyelinating Diseases [PDF]
Cells, 2021 Myelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple ...
Haruki Koike, Masahisa Katsuno
doaj +2 more sources
Bibliometric analysis of the intestinal microbiota and demyelinating diseases, particularly multiple sclerosis, since 2014 [PDF]
Frontiers in NeuroscienceBackgroundThe gut–brain axis (GBA) represents a complex, bidirectional communication network that connects the central nervous system (CNS) and the gastrointestinal system.
Ling Chen +4 more
doaj +2 more sources
Advances in Therapeutics Research for Demyelinating Diseases [PDF]
PharmaceuticalsDemyelinating diseases comprise a group of chronic and debilitating neurological disorders, with the destruction of the myelin sheath serving as the core pathological hallmark. The central pathogenesis involves immune-mediated damage to oligodendrocytes (
Jinhui Jiang +5 more
doaj +2 more sources
Differential diagnosis of demyelinating diseases: what's new? [PDF]
Arquivos de Neuro-Psiquiatria, 2022 Background: Acquired demyelinating disorders lead to overlapping visual, pyramidal, sensory, autonomic, and cerebellar deficits and may lead to severe disability.
Ana Beatriz Ayroza Galvão Ribeiro Gomes +1 more
doaj +2 more sources
COVID-19 and the risk of CNS demyelinating diseases: A systematic review [PDF]
Frontiers in Neurology, 2022 BackgroundViral infections are a proposed possible cause of inflammatory central nervous system (CNS) demyelinating diseases, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein ...
Itay Lotan +4 more
doaj +2 more sources
Therapeutic potential of neuromodulation for demyelinating diseases
Neural Regeneration Research, 2021 Neuromodulation represents a cutting edge class of both invasive and non-invasive therapeutic methods which alter the activity of neurons. Currently, several different techniques have been developed - or are currently being investigated – to treat a wide
Elliot H Choi +5 more
doaj +2 more sources
Editorial: Epidemiology of Atypical Demyelinating Diseases [PDF]
Frontiers in Neurology, 2021 Dalia Rotstein +4 more
doaj +2 more sources
Heliyon, 2021 Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa +6 more
doaj +1 more source
Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options [PDF]
Clinical and Experimental Pediatrics, 2021 Inflammatory or immune-mediated demyelinating central nervous system (CNS) syndromes include a broad spectrum of clinical phenotype and different overlapping diseases.
Yun-Jin Lee +4 more
doaj +1 more source